Drug intelligence / Profile preview

十八味杜鹃丸

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine
Modality: Small Molecules
Administration: Oral

Overview

十八味杜鹃丸 (Shiba Wei Dujuan Wan) is a traditional Tibetan medicine manufactured by Xizang Ganlu Tibetan Medicine. It is an oral pill formulated from 18 natural ingredients, with Rhododendron (*Rhododendron anthopogonoides*) serving as a primary component. In the framework of Tibetan medicine, it is indicated for the treatment of 'Long' (Wind) and 'Blood' disorders. Clinically, it is used to treat rheumatoid arthritis, gout, neuralgia, and joint swelling or pain. The formulation works by dispelling wind, unblocking collaterals, and promoting blood circulation. It is an approved pharmaceutical product in China, carrying the National Drug License Number Z54020023.

Brand names: Ganlu
Other names: Shiba Wei Dujuan Wan18-Flavor Rhododendron PillShibawei Dujuan Wan

Beyond the preview

Go deeper on 十八味杜鹃丸.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 十八味杜鹃丸.

Explore the full profile